Day

Januari 10, 2020
Positieve preklinische en klinische proof-of-concept data van Sequana Medical’s innovatieve DSR-therapie gepubliceerd in gerenommeerd cardiovasculair vaktijdschrift Data tonen potentieel aan voor behandeling van volume-overbelasting als gevolg van hartfalen   Gent, BELGIË – 10 januari 2020 – Sequana Medical NV (Euronext Brussels: SEQUA), een vernieuwer in de behandeling van vochtophoping in leveraandoeningen, maligne ascites en hartfalen,...
Read More

We would like to use cookies to better understand your use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our
Privacy & Cookie Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close